Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Anti-Obesity Prescription Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
F Hoffmann La Roche
Arena Pharmaceuticals
Novo Nordisk
VIVUS
Orexigen Therapeutics
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Bupropion and Naltrexone
Orlistat
Lorcaserin
Phentermine and Topiramate
Liraglutide
Application:
Hospitals Pharmacies
Retail Pharmacies
E-commerce
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Anti-Obesity Prescription Drugs Industry Overview
-
1.1.1 Anti-Obesity Prescription Drugs Market Scope and Market Segments
-
1.1.2 Anti-Obesity Prescription Drugs Industry Characteristics
-
1.1.3 Global and China Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Anti-Obesity Prescription Drugs Production Value and Growth Rate (2017-2028)
-
1.2 Global Anti-Obesity Prescription Drugs Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Bupropion and Naltrexone
-
1.2.2 Orlistat
-
1.2.3 Lorcaserin
-
1.2.4 Phentermine and Topiramate
-
1.2.5 Liraglutide
-
1.3 Global Anti-Obesity Prescription Drugs Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Hospitals Pharmacies
-
1.3.2 Retail Pharmacies
-
1.3.3 E-commerce
-
1.4 Market Analysis by Region
-
1.4.1 North America Anti-Obesity Prescription Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Anti-Obesity Prescription Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Anti-Obesity Prescription Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Anti-Obesity Prescription Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Anti-Obesity Prescription Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Anti-Obesity Prescription Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Anti-Obesity Prescription Drugs Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Anti-Obesity Prescription Drugs Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Anti-Obesity Prescription Drugs Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Anti-Obesity Prescription Drugs Industry Porter's Five Forces Model Analysis
-
2.2.3 Anti-Obesity Prescription Drugs Industry PEST Analysis
-
2.3 Anti-Obesity Prescription Drugs Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Anti-Obesity Prescription Drugs Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Anti-Obesity Prescription Drugs Industry
Chapter 3 Global and China Anti-Obesity Prescription Drugs Market, by Manufacturer
-
3.1 Global and China Anti-Obesity Prescription Drugs Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Anti-Obesity Prescription Drugs Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Anti-Obesity Prescription Drugs Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Anti-Obesity Prescription Drugs Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Anti-Obesity Prescription Drugs Market Top 3 Players
Chapter 4 Global and China Anti-Obesity Prescription Drugs Market, by Type (2017-2028)
-
4.1 Anti-Obesity Prescription Drugs Market Trend, by Type
-
4.2 Global Anti-Obesity Prescription Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Anti-Obesity Prescription Drugs Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Anti-Obesity Prescription Drugs Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Anti-Obesity Prescription Drugs Price Trend, by Type (2017-2028)
-
4.3 China Anti-Obesity Prescription Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Anti-Obesity Prescription Drugs Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Anti-Obesity Prescription Drugs Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Anti-Obesity Prescription Drugs Price Trend, by Type (2017-2028)
Chapter 5 Global and China Anti-Obesity Prescription Drugs Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Anti-Obesity Prescription Drugs Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Anti-Obesity Prescription Drugs Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Anti-Obesity Prescription Drugs Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Anti-Obesity Prescription Drugs Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Anti-Obesity Prescription Drugs Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Anti-Obesity Prescription Drugs Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Anti-Obesity Prescription Drugs Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Anti-Obesity Prescription Drugs Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Anti-Obesity Prescription Drugs Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Anti-Obesity Prescription Drugs Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Anti-Obesity Prescription Drugs Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Anti-Obesity Prescription Drugs Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Anti-Obesity Prescription Drugs Market Analysis
-
7.1 North America Anti-Obesity Prescription Drugs Market, by Type
-
7.2 North America Anti-Obesity Prescription Drugs Market, by Application
-
7.3 North America Anti-Obesity Prescription Drugs Market Analysis and Forecast, by Country
-
7.3.1 United States Anti-Obesity Prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Anti-Obesity Prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Anti-Obesity Prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Anti-Obesity Prescription Drugs Market Analysis
-
8.1 Europe Anti-Obesity Prescription Drugs Market, by Type
-
8.2 Europe Anti-Obesity Prescription Drugs Market, by Application
-
8.3 Europe Anti-Obesity Prescription Drugs Market Analysis and Forecast, by Country
-
8.3.1 Germany Anti-Obesity Prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Anti-Obesity Prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Anti-Obesity Prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Anti-Obesity Prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Anti-Obesity Prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Anti-Obesity Prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Anti-Obesity Prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Anti-Obesity Prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Anti-Obesity Prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Anti-Obesity Prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Anti-Obesity Prescription Drugs Market Analysis
-
9.1 APAC Anti-Obesity Prescription Drugs Market, by Type
-
9.2 APAC Anti-Obesity Prescription Drugs Market, by Application
-
9.3 APAC Anti-Obesity Prescription Drugs Market Analysis and Forecast, by Country
-
9.3.1 China Anti-Obesity Prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Anti-Obesity Prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Anti-Obesity Prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Anti-Obesity Prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Anti-Obesity Prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Anti-Obesity Prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Anti-Obesity Prescription Drugs Market Analysis
-
10.1 Latin America, Middle East and Africa Anti-Obesity Prescription Drugs Market, by Type
-
10.2 Latin America, Middle East and Africa Anti-Obesity Prescription Drugs Market, by Application
-
10.3 Latin America, Middle East and Africa Anti-Obesity Prescription Drugs Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Anti-Obesity Prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Anti-Obesity Prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Anti-Obesity Prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Anti-Obesity Prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Anti-Obesity Prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Anti-Obesity Prescription Drugs Company Profiles
-
11.1 F Hoffmann La Roche
-
11.1.1 F Hoffmann La Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 F Hoffmann La Roche Anti-Obesity Prescription Drugs Product Profiles, Application and Specification
-
11.1.3 F Hoffmann La Roche Anti-Obesity Prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Arena Pharmaceuticals
-
11.2.1 Arena Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Product Profiles, Application and Specification
-
11.2.3 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Novo Nordisk
-
11.3.1 Novo Nordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Novo Nordisk Anti-Obesity Prescription Drugs Product Profiles, Application and Specification
-
11.3.3 Novo Nordisk Anti-Obesity Prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 VIVUS
-
11.4.1 VIVUS Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 VIVUS Anti-Obesity Prescription Drugs Product Profiles, Application and Specification
-
11.4.3 VIVUS Anti-Obesity Prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Orexigen Therapeutics
-
11.5.1 Orexigen Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Orexigen Therapeutics Anti-Obesity Prescription Drugs Product Profiles, Application and Specification
-
11.5.3 Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Anti-Obesity Prescription Drugs Industry Investment Prospect and Risk Assessment
-
12.1 Anti-Obesity Prescription Drugs Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Anti-Obesity Prescription Drugs Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure China Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Global Anti-Obesity Prescription Drugs Production Value and Growth Rate (2017-2028)
-
Figure China Anti-Obesity Prescription Drugs Production Value and Growth Rate (2017-2028)
-
Figure Global Anti-Obesity Prescription Drugs Market Size and Growth Rate of Bupropion and Naltrexone (2017-2028)
-
Figure Global Anti-Obesity Prescription Drugs Market Size and Growth Rate of Orlistat (2017-2028)
-
Figure Global Anti-Obesity Prescription Drugs Market Size and Growth Rate of Lorcaserin (2017-2028)
-
Figure Global Anti-Obesity Prescription Drugs Market Size and Growth Rate of Phentermine and Topiramate (2017-2028)
-
Figure Global Anti-Obesity Prescription Drugs Market Size and Growth Rate of Liraglutide (2017-2028)
-
Figure Global Anti-Obesity Prescription Drugs Market Size and Growth Rate of Hospitals Pharmacies (2017-2028)
-
Figure Global Anti-Obesity Prescription Drugs Market Size and Growth Rate of Retail Pharmacies (2017-2028)
-
Figure Global Anti-Obesity Prescription Drugs Market Size and Growth Rate of E-commerce (2017-2028)
-
Figure North America Anti-Obesity Prescription Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Anti-Obesity Prescription Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Anti-Obesity Prescription Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Anti-Obesity Prescription Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Anti-Obesity Prescription Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Anti-Obesity Prescription Drugs Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Anti-Obesity Prescription Drugs Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Anti-Obesity Prescription Drugs Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Anti-Obesity Prescription Drugs Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Anti-Obesity Prescription Drugs Market Share, by Manufacturer in 2021
-
Figure Global and China Anti-Obesity Prescription Drugs Market Share, by Manufacturer in 2022
-
Table Global Anti-Obesity Prescription Drugs Sales Volume, by Type (2017-2028)
-
Table Global Anti-Obesity Prescription Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Global Anti-Obesity Prescription Drugs Sales Volume Share, by Type (2017-2028)
-
Table Global Anti-Obesity Prescription Drugs Sales Value, by Type (2017-2028)
-
Table Global Anti-Obesity Prescription Drugs Sales Value Share, by Type (2017-2028)
-
Figure Global Anti-Obesity Prescription Drugs Price Trend, by Type (2017-2028)
-
Table China Anti-Obesity Prescription Drugs Sales Volume, by Type (2017-2028)
-
Table China Anti-Obesity Prescription Drugs Sales Volume Share, by Type (2017-2028)
-
Figure China Anti-Obesity Prescription Drugs Sales Volume Share, by Type (2017-2028)
-
Table China Anti-Obesity Prescription Drugs Sales Value, by Type (2017-2028)
-
Table China Anti-Obesity Prescription Drugs Sales Value Share, by Type (2017-2028)
-
Figure China Anti-Obesity Prescription Drugs Price Trend, by Type (2017-2028)
-
Table Global Anti-Obesity Prescription Drugs Sales Volume, by Application (2017-2028)
-
Table Global Anti-Obesity Prescription Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Global Anti-Obesity Prescription Drugs Sales Volume Share, by Application (2017-2028)
-
Table Global Anti-Obesity Prescription Drugs Sales Value, by Application (2017-2028)
-
Table Global Anti-Obesity Prescription Drugs Sales Value Share, by Application (2017-2028)
-
Figure Global Anti-Obesity Prescription Drugs Sales Value Share, by Application (2017-2028)
-
Table China Anti-Obesity Prescription Drugs Sales Volume, by Application (2017-2028)
-
Table China Anti-Obesity Prescription Drugs Sales Volume Share, by Application (2017-2028)
-
Figure China Anti-Obesity Prescription Drugs Sales Volume Share, by Application (2017-2028)
-
Table China Anti-Obesity Prescription Drugs Sales Value, by Application (2017-2028)
-
Table China Anti-Obesity Prescription Drugs Sales Value Share, by Application (2017-2028)
-
Figure China Anti-Obesity Prescription Drugs Sales Value Share, by Application (2017-2028)
-
Figure China Anti-Obesity Prescription Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure North America Anti-Obesity Prescription Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Anti-Obesity Prescription Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Anti-Obesity Prescription Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Anti-Obesity Prescription Drugs Production, Import, Consumption and Export (2017-2022)
-
Table North America Anti-Obesity Prescription Drugs Sales Volume, by Type (2017-2028)
-
Table North America Anti-Obesity Prescription Drugs Sales Volume Share, by Type (2017-2028)
-
Figure North America Anti-Obesity Prescription Drugs Sales Volume Share, by Type (2017-2028)
-
Table North America Anti-Obesity Prescription Drugs Sales Volume, by Application (2017-2028)
-
Table North America Anti-Obesity Prescription Drugs Sales Volume Share, by Application (2017-2028)
-
Figure North America Anti-Obesity Prescription Drugs Sales Volume Share, by Application (2017-2028)
-
Figure United States Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure United States Anti-Obesity Prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Canada Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Anti-Obesity Prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Anti-Obesity Prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Table Europe Anti-Obesity Prescription Drugs Sales Volume, by Type (2017-2028)
-
Table Europe Anti-Obesity Prescription Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Europe Anti-Obesity Prescription Drugs Sales Volume Share, by Type (2017-2028)
-
Table Europe Anti-Obesity Prescription Drugs Sales Volume, by Application (2017-2028)
-
Table Europe Anti-Obesity Prescription Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Europe Anti-Obesity Prescription Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Germany Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Anti-Obesity Prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure UK Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure UK Anti-Obesity Prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure France Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure France Anti-Obesity Prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Italy Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Anti-Obesity Prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Anti-Obesity Prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Spain Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Anti-Obesity Prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Anti-Obesity Prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Poland Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Anti-Obesity Prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Russia Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Anti-Obesity Prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Anti-Obesity Prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Table APAC Anti-Obesity Prescription Drugs Sales Volume, by Type (2017-2028)
-
Table APAC Anti-Obesity Prescription Drugs Sales Volume Share, by Type (2017-2028)
-
Figure APAC Anti-Obesity Prescription Drugs Sales Volume Share, by Type (2017-2028)
-
Table APAC Anti-Obesity Prescription Drugs Sales Volume, by Application (2017-2028)
-
Table APAC Anti-Obesity Prescription Drugs Sales Volume Share, by Application (2017-2028)
-
Figure APAC Anti-Obesity Prescription Drugs Sales Volume Share, by Application (2017-2028)
-
Figure China Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure China Anti-Obesity Prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Japan Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Anti-Obesity Prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Anti-Obesity Prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure India Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure India Anti-Obesity Prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Anti-Obesity Prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Anti-Obesity Prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Anti-Obesity Prescription Drugs Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Anti-Obesity Prescription Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Anti-Obesity Prescription Drugs Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Anti-Obesity Prescription Drugs Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Anti-Obesity Prescription Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Anti-Obesity Prescription Drugs Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Anti-Obesity Prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Anti-Obesity Prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Anti-Obesity Prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Anti-Obesity Prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Anti-Obesity Prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Table F Hoffmann La Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table F Hoffmann La Roche Product Profiles, Application and Specification
-
Table F Hoffmann La Roche Anti-Obesity Prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Arena Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Arena Pharmaceuticals Product Profiles, Application and Specification
-
Table Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novo Nordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novo Nordisk Product Profiles, Application and Specification
-
Table Novo Nordisk Anti-Obesity Prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table VIVUS Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table VIVUS Product Profiles, Application and Specification
-
Table VIVUS Anti-Obesity Prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Orexigen Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Orexigen Therapeutics Product Profiles, Application and Specification
-
Table Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
